Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

334.32 +6.30 (+1.92%)
Streaming Delayed Price Updated: 3:30 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Insulet Corp (PODD) Shows Strong Technical and Fundamental Momentum ↗
Discover how Insulet Corp (PODD) combines strong technical uptrends with high-growth fundamentals, presenting a potential market leader for growth investors. 
Via Chartmill
News headline image
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Insulet Corp (NASDAQ:PODD) Passes Stringent Growth Screen ↗
Discover how Insulet Corp exemplifies a powerful growth investing system, showcasing strong earnings, soaring sales, and impressive cash flow. 
Via Chartmill
News headline image
Gapping S&P500 stocks in Thursday's session ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Price Over Earnings Overview: Insulet ↗
 
Via Benzinga
News headline image
Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter ↗
Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad. 
Via Investor's Business Daily
News headline image
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
News headline image
Insulet’s (NASDAQ:PODD) Q3: Strong Sales
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 29.9% year on year to $706.3 million. On top of that, next... 
Via StockStory
News headline image
Insulet Reports Third Quarter 2025 Results
From Insulet Corporation
Via Business Wire
News headline image
Examining the Future: Insulet's Earnings Outlook ↗
 
Via Benzinga
News headline image
Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' ↗
Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade. 
Via Benzinga
News headline image
Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
News headline image
Peering Into Insulet Corp's Recent Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
From Insulet Corporation
Via Business Wire
News headline image
INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum ↗
Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors. 
Via Chartmill
News headline image
1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing ↗
Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers. 
Via Chartmill
News headline image
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
From Insulet Corporation
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD) ↗
Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth. 
Via Chartmill
News headline image
Insulet to Host Investor Day on November 20, 2025
From Insulet Corporation
Via Business Wire
News headline image
Discover which S&P500 stocks are making waves on Thursday. ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗
Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization... 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts ↗
6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives. 
Via Benzinga
News headline image
Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability ↗
Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential. 
Via Chartmill
News headline image
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
News headline image
Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.